Literature DB >> 10829265

The newer macrolides: azithromycin and clarithromycin.

J M Zuckerman1.   

Abstract

Azithromycin and clarithromycin are two relatively new macrolide antimicrobial agents. Although azithromycin and clarithromycin are structural analogues of erythromycin, they offer distinct advantages in comparison. This article reviews the pharmacokinetics, antimicrobial activity, clinical use, and adverse affects of these antimicrobial agents.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10829265     DOI： 10.1016/s0891-5520(05)70257-9

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  10 in total

1.  Risk of cardiovascular effects with azithromycin.

Authors:  Ramachandran Kumaresan; Subish Palaian; Santosh Thapa; Pathiyil Ravi Shankar
Journal:  J Clin Diagn Res       Date:  2015-01-01

2.  A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.

Authors:  Astrid Milić; Vlatka Bencetić Mihaljević; Jovica Ralić; Ana Bokulić; Danijela Nožinić; Branka Tavčar; Boris Mildner; Vesna Munić; Ivica Malnar; Jasna Padovan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-10-10       Impact factor: 2.441

3.  The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases.

Authors:  Ding Hui; Fen Yan; Ru-Hua Chen
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

4.  Evidence of mutations conferring resistance to clarithromycin in wastewater and activated sludge.

Authors:  Anna Gnida; Ewa Felis; Aleksandra Ziembińska-Buczyńska; Aneta Łuczkiewicz; Joanna Surmacz-Górska; Krystyna Olańczuk-Neyman
Journal:  3 Biotech       Date:  2019-11-29       Impact factor: 2.406

5.  Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells.

Authors:  Miaomiao Chen; Tuo Yang; Xiangiyu Meng; Tieying Sun
Journal:  Mol Med Rep       Date:  2015-01-20       Impact factor: 2.952

Review 6.  Antimicrobial therapy in childhood asthma and wheezing.

Authors:  Arne Simon; Oliver Schildgen
Journal:  Treat Respir Med       Date:  2006

7.  C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.

Authors:  Donald N Ngwa; Sanjay K Singh; Alok Agrawal
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 8.786

8.  Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration.

Authors:  Wener Li; Xiaojing Luo; Mareike S Poetsch; Reinhard Oertel; Kapil Nichani; Martin Schneider; Anna Strano; Marcel Hasse; Robert-Patrick Steiner; Lukas Cyganek; Karina Hettwer; Steffen Uhlig; Kirsten Simon; Kaomei Guan; Mario Schubert
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-12

9.  Azithromycin synergistically enhances anti-proliferative activity of vincristine in cervical and gastric cancer cells.

Authors:  Xuezhang Zhou; Yuyan Zhang; Yong Li; Xiujing Hao; Xiaoming Liu; Yujiong Wang
Journal:  Cancers (Basel)       Date:  2012-12-04       Impact factor: 6.639

10.  Relative effectiveness of azithromycin in killing intracellular Porphyromonas gingivalis.

Authors:  Pin-Chuang Lai; John D Walters
Journal:  Clin Exp Dent Res       Date:  2016-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.